e-learning
resources
Milan 2017
Monday, 11.09.2017
Microbiology and laboratory techniques to monitor NTM infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease
E. Hagiwara (Yokohama, Japan)
Source:
International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Session:
Microbiology and laboratory techniques to monitor NTM infections
Session type:
Thematic Poster
Number:
2736
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Hagiwara (Yokohama, Japan). Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease. 2736
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Effusions related to TB
Laboratory diagnosis of tuberculosis
Related content which might interest you:
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Pulmonary tuberculosis among elderly and senile-aged patients depending on Mycobacterium strains
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Genome-wide association study in patients with pulmonary
Mycobacterium avium
complex disease
Source: Eur Respir J, 58 (2) 1902269; 10.1183/13993003.02269-2019
Year: 2021
Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course
Source: Eur Respir J , 49 (3) 1600537; DOI: 10.1183/13993003.00537-2016
Year: 2017
A case of familial pulmonary
Mycobacterium avium
complex disease – experience in Japan
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
The latent tuberculosis infection among household contacts of newly diagnosed patients with sputum-positive pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 142s
Year: 2003
Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Clinical features of pulmonary
Mycobacterium avium intracellulare
complex disease with a solitary pulmonary nodule in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005
The utility of a serodiagnosis for
mycobacterium avium
complex pulmonary disease diagnosed by the single available bronchial wash
Source: Eur Respir J 2004; 24: Suppl. 48, 206s
Year: 2004
Clinical study of mycobacterium avium complex pulmonary disease complicated by interstitial pneumonia
Source: Annual Congress 2011 - Non-tuberculous mycobacteria pulmonary infections
Year: 2011
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Long-term survival of patients with
mycobacterium avium- intracellulare
complex pulmonary disease (MAC-PD)
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Treatment effectiveness among newly diagnosed patients with expanded pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept